
Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma
Keywords: UHPLC-ESI-QTOF-MS; Mouse plasma; D-peptide; Amyloid-β peptide; Therapeutic compound; Alzheimer's disease;